EUIPO trademark

Fastprobe

RegisteredEUIPOWord markClass 1Class 5Class 9Class 10

"Fastprobe" is a word mark owned by ZytoVision GmbH, filed at the EUIPO on March 11, 2024. It is registered and covers classes 1, 5, 9 and 10.

View ZytoVision GmbH portfolioGet this data via the API
Official EUIPO record
Fastprobe
Word mark as filed with the EUIPO
Status
Registered
Since August 29, 2024
Filed
March 11, 2024
Registered
August 28, 2024
Expires
March 11, 2034
Application no.
018996907
Registration no.
018996907
Office
EUIPO
European Union Intellectual Property Office
Mark type
Word mark
4 classes
Ownership

Who owns Fastprobe

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

ZytoVision GmbH

23 trademarks in the portfolioView company

Representative

Meissner Bolte Patentanwälte Rechtsanwälte Partnerschaft MBB

Meissner Bolte Patentanwälte Rechtsanwälte Partnerschaft MBB

Goods and services

What the mark covers

The products and services Fastprobe is filed for, grouped by Nice class.

  • Chemicals for use in industry and science; Chemicals, Biochemicals, for use in the following fields: pathology, Genetics, Human genetics, molecular pathologies, Molecular biology, Microbiology, Biotechnology, Laboratory medicine; Chemicals and biochemicals for histology, cytology, immunohistology, immunohistochemistry, in situ hybridisation, PCR (polymerase chain reaction), NGS (next generation sequencing), microarray hybridisation (genetic chip or biochip hybridisation), flow cytometry services and isolation of biomolecules including DNA, RNA and proteins; Nucleic acids, including the following products: DNA, RNA, Oligonucleotides, polynucleotides, synthetic genes, polynucleotides, Marked nucleic acids, modified nucleic acids, Proteins, including the following products: Peptides, Recombinant proteins and Marked proteins, Antibodies, Cells, Fabrics, Tissue sections, nucleic acids, proteins and cells immobilised on carriers

  • Pharmaceuticals and medical preparations; Medical preparations for diagnostics; Medical preparations for in-vitro diagnostics; Pharmaceuticals, Pharmaceutical preparations, medical products, Medical preparations, Chemical products, chemical preparations, Biochemical products, Biochemical preparations, For medical purposes, for use in the following fields: pathology, Genetics, Human genetics, molecular pathologies, Molecular biology, Microbiology, biotechnology, laboratory medicine; Pharmaceutical, medicated, chemical and biochemicals and preparations for medical purposes for histology, cytology, immunohistology, immunohistochemistry, in situ hybridisation, PCR (polymerase chain reaction), NGS (next generation sequencing), microarray hybridisation (genetic chip or biochip hybridisation), flow cytometry services and isolation of biomolecules including DNA, RNA and proteins; Nucleic acids, including the following products: DNA, RNA, oligonucleotides, polynucleotides, Marked nucleic acids, modified nucleic acids, proteins, including the following products: Peptides, recombinant proteins and Marked proteins, Antibodies, Cells, Fabrics, Tissue sections, nucleic acids, proteins and cells immobilised on carriers

  • Scientific research and laboratory apparatus, educational apparatus and simulators; Analysis apparatus for conducting and evaluating histology, cytology, immunohistology, immunohistochemistry, in situ hybridisation, PCR (polymerase chain reaction), NGS (next generation sequencing), microarray hybridisation (genetic chip or biochip hybridisation), flow cytometry and isolation of biomolecules including DNA, RNA and proteins; Research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids, Analysis apparatus for research laboratories for measuring, testing and examining tissue, cells and biomolecules including DNA, RNA and proteins

  • Medical apparatus and instruments; Medical instruments; Medical analytical apparatus for medical purposes; Automatic analyzers for medical diagnosis; Physical analyzers for medical use; Genetic testing apparatus for medical purposes

History

What has happened so far

Steps recorded by the EUIPO, newest first.

  1. Bulletin 2024/165 Section B.1
  2. Bulletin 2024/094 Section A.1
FAQ

About Fastprobe

Who owns the trademark "Fastprobe"?

The EUIPO trademark "Fastprobe" (application 018996907) is owned by ZytoVision GmbH.

What is the status of "Fastprobe"?

Its status at the EUIPO is: registered.

When was "Fastprobe" registered?

It was registered on August 28, 2024 and is due to expire on March 11, 2034.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull Fastprobe and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d45b8-8a99-7658-aa88-7de35ce318d6
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d45b8-8a99-7658-aa88-7de35ce318d6",
  "object": "trademark",
  "mark_text": "Fastprobe",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "EM",
  "application_number": "018996907",
  "filing_date": "2024-03-11",
  "nice_classes": [
    1,
    5,
    9,
    10
  ],
  "owners": [
    {
      "name": "ZytoVision GmbH",
      "entity_id": "ent_019ebb42-4bb0-720d-b356-e1fc66cf253e"
    }
  ]
}